XTX Topco’s ProKidney PROK Stock Holding History

XTX Topco’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,267	Closed	-$40.8K	–	2803
2024 Q3	$40.8K	Buy	+21,267	New	+$48.3K	﹤0.01%	1723
2024 Q1	–	Sell	-73,032	Closed	-$130K	–	2218
2023 Q4	$130K	Buy	73,032 +11,121	+18%	+$23.8K	0.03%	1071
2023 Q3	$284K	Buy	+61,911	New	+$593K	0.05%	768

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

XTX Topco's PROK Position: Q4 2024 in Review

XTX Topco sold out of ProKidney (PROK) in Q4 2024, closing a stake of 21,267 shares — an estimated $40.8K sold.

XTX Topco first reported a position in PROK in Q3 2023 and held it in 3 quarters. The position peaked at $284K in Q3 2023. 74 funds tracked by Wall St. Rank hold PROK as of Q4 2024.

XTX Topco reported no remaining ProKidney position as of Q4 2024 after selling out during the quarter.
XTX Topco sold 21,267 ProKidney shares in Q4 2024, an estimated $40.8K.
XTX Topco first reported a position in ProKidney in Q3 2023 and held it in 3 quarters.
XTX Topco's ProKidney position peaked at $284K in Q3 2023.
74 funds tracked by Wall St. Rank held ProKidney as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.